{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-053359","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.696983+00:00","generated_at":"2026-06-01T04:08:16.848254+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Hoth Therapeutics board amends bylaws to clarify shareholder voting entitlement","bullets":["Board approved Amendment No. 2 to Amended and Restated Bylaws on June 14, 2024.","Amendment restates Article II, Section 2.7(b) regarding shareholders entitled to vote at meetings.","Effective immediately; no impact on financials or operations disclosed.","Exhibit 3.1 filed but not appended; details limited to procedural clarification."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-053359","json":"https://secwatch.observer/filing/0001213900-24-053359.json","markdown":"https://secwatch.observer/filing/0001213900-24-053359.md","text":"https://secwatch.observer/filing/0001213900-24-053359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/0001213900-24-053359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/ea0207966-8k_hoththera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:08:16.848254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}